NAD+ IV Therapy: What to Expect & Where to Get It

Table of Contents

NAD+ IV therapy sends nicotinamide adenine dinucleotide (NAD+) into the bloodstream via an intravenous (IV) infusion. The infusion appointment may include a physical assessment, vital-sign checks, and IV placement. The infusion itself is slow, with careful clinical monitoring throughout. NAD+ plays an important role in normal cellular function. However, current evidence supporting IV NAD+ therapy for anti-aging and general wellness remains limited.

NAD+ IV therapy is offered in five main settings: physician-led longevity and wellness clinics, medical IV therapy clinics, multi-location wellness companies, mobile IV services that travel to a location, and regional infusion centers. Availability, clinician involvement, product formulation, and pricing vary across all of them. Mobile services vary the most, because the rules governing them are set state by state.

This guide explains what to expect before, during, and after NAD+ IV therapy. It also reviews the current clinical evidence, discusses potential side effects and risks, and explains how to evaluate clinics that offer this treatment. More detailed discussions of potential benefits, costs, and comparisons with NAD+ injections or supplements are covered in separate resources.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. NAD+ IV therapy may not be appropriate for everyone. A licensed healthcare provider can help determine whether this treatment is appropriate based on an individual’s health history, medications, and treatment goals.

NAD+ IV Therapy at a Glance

What it is: NAD+ IV therapy delivers nicotinamide adenine dinucleotide directly into the bloodstream through an intravenous infusion.
What the evidence shows: NAD+ is essential for normal cellular function, but evidence supporting NAD+ IV therapy for anti-aging, energy, cognitive performance, or general wellness remains limited.
What to expect: Treatment typically involves a health screening, IV placement, monitoring during the infusion, and a brief recovery period afterward. Treatment time varies based on the dose, infusion rate, and individual tolerance.
Possible risks: Infusion-related symptoms can occur, and NAD+ IV therapy also carries the usual risks associated with IV treatment, including bruising, irritation, infection, and other IV-line complications.
Product quality matters: Some injectable NAD+ products are compounded rather than FDA-approved, making product sourcing and appropriate compounding practices important considerations.
Choosing a provider: Look for appropriate medical screening, qualified clinicians, clear product sourcing, monitoring during treatment, and established procedures for managing adverse reactions.

What Is NAD+ IV Therapy?

NAD+ is a naturally occurring coenzyme found in every cell of the body. Cells use it to convert nutrients into energy. The cofactor supports metabolism, DNA repair, and other normal cellular processes.

At the start of an NAD+ therapy session, a clinician administers a sterile NAD+ solution through a peripheral IV catheter in the arm or hand. The IV therapy bypasses the digestive system to deliver the solution directly into the bloodstream.

NAD+ is similar to nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Each is involved in NAD+ metabolism, but they are not interchangeable. NR and NMN differ in that they are precursor molecules the body can convert into NAD+. However, NADH is a reduced form of the coenzyme involved in cellular energy production.

The distinction between the biological role of NAD+ and the effects of NAD+ IV therapy is important. NAD+ is essential for healthy cell function, but current evidence has not established it improves energy or enhances cognitive performance. Additional high-quality clinical trials are necessary to determine whether IV NAD+ therapy provides meaningful health benefits since human studies are limited.

What to Expect Before, During, and After NAD+ IV Therapy

A typical NAD+ IV therapy clinic visit includes a health screening and assessment. Next, an IV is placed in the hand or arm before the infusion begins. Each clinic follows its specific protocols with a shared goal of administering the infusion safely while monitoring for any symptoms that develop during treatment.

Most NAD+ IV therapy treatments are done in three phases: pre-infusion preparation, monitoring during treatment, and brief recovery after the infusion is complete.

Before the Appointment

The clinician performs a medical screening before starting therapy to ensure treatment is appropriate. The evaluation also helps identify any health conditions or other factors, such as medications, that could impact treatment safety.

A healthcare provider likely also reviews any allergies and dietary supplements. Then, any health history related to chronic medical conditions, previous infusion reactions, and pregnancy is considered for setting treatment goals. It also helps determine whether additional evaluation is needed before proceeding with therapy.

The clinical assessment includes baseline vital signs like blood pressure and temperature. Additional assessments may also be performed according to the clinic’s protocols.

People considering NAD+ IV therapy may wish to ask their healthcare provider questions before treatment begins. For example, what is the dose and how is the infusion rate determined? Preparation instructions may vary between providers. Some may suggest eating before and increasing fluid intake, while others consider an individual’s health history for preinfusion guidance. It is best to follow the specific instructions provided by the healthcare team instead of a universal recommendation.

During the Infusion

An IV is inserted before starting the infusion. The healthcare professional usually looks for a vein in the hand or arm first. Patients remain under observation throughout treatment so clinicians can monitor for symptoms and adjust care if needed.

Next, the infusion is delivered at a controlled rate. Some IV infusions are completed relatively quickly, but NAD+ is typically infused slowly since it influences how well the treatment is tolerated. The total infusion time depends on the prescribed dose and how the patient responds during treatment.

Some clinics may encourage patients to relax during the infusion by reading or listening to music. Staff frequently check on patients throughout the appointment and may periodically assess vital signs and check symptoms.

A 2026 real-world study published in the Frontiers in Aging found that participants receiving NAD+ IV reported gastrointestinal and cardiovascular symptoms, including abdominal cramping, nausea, vomiting, diarrhea, increased heart rate, throat discomfort, and chest pressure. Patients reported symptoms like nausea and chest pressure during treatment. However, the reported symptoms resolved at the end of treatment. Since the study included a small pool of participants and lacked a placebo comparison, the findings should be interpreted cautiously rather than generalized to all patients.

Individuals receiving the infusion should notify clinic staff immediately if they start to feel any symptoms such as worsening abdominal pain or throat discomfort. If symptoms occur, healthcare professionals may slow or stop the infusion based on the patient’s condition. Signs of anaphylaxis, such as shortness of breath and throat swelling, are a medical emergency. Chest symptoms and breathing difficulty need immediate medical assessment and are never an expected part of treatment.

After the Infusion

Once the infusion is complete, the IV catheter is removed with gentle pressure applied at the site to reduce bleeding or bruising. Patients are often asked to remain under observation briefly before leaving the clinic. During this time, clinicians likely review post-treatment instructions and explain when additional medical evaluation may be needed.

Patients should follow any individualized aftercare instructions provided by their healthcare team. The IV site should be monitored for redness, swelling, drainage, or worsening pain, which may suggest irritation or infection.

Anyone who develops persistent or worsening symptoms after leaving the clinic should contact their provider. Symptoms such as severe chest pain or signs of an allergic reaction are a medical emergency and require immediate evaluation.

The same 2026 observational study also found no post-infusion adverse events during the 30-day follow-up period. Again, that study was small and imperfect, so additional research is needed before drawing broader conclusions about the long-term safety of NAD+ IV therapy.

How Long Does NAD+ IV Therapy Take?

There is no standard length for an NAD+ IV therapy session. Treatment time is based on prescribed dose, infusion rate, and how well the patient tolerates the infusion.

Commercial NAD+ IV therapy providers will order treatment sessions lasting anywhere from an hour to four hours. Appointment lengths vary by clinic and treatment protocol. Some patients need additional time for their initial infusion appointment. These estimates reflect individual provider preferences rather than established clinical guidelines, so they should be viewed as general examples only, not standard treatment recommendations.

The prescribed infusion rate plays an important role in treatment duration and tolerability. If the NAD+ infusion moves too quickly, patients may develop nausea or other infusion-related symptoms. If this happens, the treating clinician may reduce the infusion rate or temporarily pause treatment. A slower infusion rate may improve tolerability, but it can also extend the appointment time.

Clinics have various protocols they follow. Some providers offer single infusions for patients interested in trying NAD+ IV therapy, while others recommend multiple sessions over several days or even weeks. The individual clinics and providers have their own recommendations and should not be interpreted as evidence-based standards of care.

It is appropriate to ask healthcare providers how long their appointment is expected to last when considering NAD+ IV therapy. The clinician will also likely discuss when additional observation is needed after the infusion and how the clinic decides the appropriate infusion rate for each patient.

What Are the Possible Side Effects and Risks?

NAD+ IV therapy can cause infusion-related symptoms and carries risks associated with intravenous treatment itself. Since many NAD+ products are compounded rather than FDA-approved, the quality and sterile compounding practices are important safety considerations.

Even though many people tolerate IV therapy without serious complications, every intravenous treatment carries some degree of risk. Knowing these risks can help patients make informed decisions and recognize when they should notify their healthcare provider.

Infusion-Related Symptoms

Infusion-related symptoms are more likely when the infusion is administered too quickly. Patients should report any new or worsening symptoms immediately so the clinical team can determine if the infusion should be adjusted or stopped.

Infusion rate appears to influence tolerability. Clinicians look for non-routine side effects such as chest pressure, throat tightness, and difficulty breathing since they may indicate a medical emergency.

Risks Associated With the IV Line

There are risks related to the IV itself rather than the NAD+ solution. The complications are similar to those seen with other intravenous treatments.

The placement of an IV catheter can cause temporary discomfort, bruising and even minor bleeding at the insertion site. However, patients may also develop infiltration, which occurs when IV fluid leaks from the vein into the surrounding tissue. The infiltration can cause swelling and pain and usually requires the catheter to be removed and replaced.

Phlebitis is another possible complication with IV insertion. Phlebitis is inflammation of the vein and causes redness, warmth, tenderness and swelling along the vein after the catheter is placed. Most cases improve with conservative treatment, such as removing the IV line and applying ice. However, persistent symptoms should be evaluated by a healthcare professional.

All invasive procedures carry a risk of infection and bleeding. The IV catheter can become dislodged or occluded during a long infusion. Local infections can also spread into the bloodstream. Since NAD+ infusions run for several hours, the IV line needs to stay in place longer and should be monitored closely throughout the infusion. Reputable clinics work to lower these risks by following infection control practices. All IVs should be placed using sterile technique with close site monitoring for the duration of the infusion.

Product Quality and Sterile Compounding Concerns

The quality of the NAD+ product is a vital part of treatment safety. Some injectable NAD+ formulations are compounded products and not regulated by the U.S. Food and Drug Administration (FDA). Instead, regulation is split between state boards of pharmacy and federal oversight under the Federal Food, Drug, and Cosmetic Act.

According to the FDA, compounded drugs are not verified for their safety, effectiveness or quality before they are marketed. Understanding this distinction is important because compounded medications do not undergo the same pre-market review required for FDA-approved medications.

The FDA has also addressed the ingredients used in these preparations. In a reminder to compounders, the agency stated that food-grade NAD+, which is intended for oral supplements, is not suitable for injectable or IV products, citing contamination risk and reported adverse events. Food-grade material is manufactured to purity standards for swallowing, not to sterility standards for the bloodstream.

The FDA reports adverse events associated with injectable NAD+ products. Reported reactions included severe chills, shaking, vomiting and fatigue with some cases requiring medical intervention. Some of these reported reactions were consistent with excessive endotoxin, which is a bacterial contaminant that can trigger fever and a significant inflammatory response when present in injectable products. The reports further highlight the importance of sterile compounding practices and careful quality control during the manufacturing process.

A person considering NAD+ IV therapy may want to ask where the injectable product is sourced, whether it’s compounded and which pharmacy or outsourcing facility prepares the medication. That question has a specific answer worth knowing. Sterile injectable compounding takes place either at a 503A pharmacy, which prepares products for individual patients against a prescription, or at a 503B outsourcing facility, which registers with the FDA and is subject to current good manufacturing practice (cGMP) inspection. Oversight differs between the two: state boards of pharmacy generally have primary day-to-day oversight of 503A pharmacies, while 503B outsourcing facilities register with the FDA and are subject to current good manufacturing practice (CGMP) requirements. Asking which type of facility supplies the product, and whether preparation follows USP 797, produces a more useful answer than asking whether a clinic uses a high-quality product. A reputable clinic should also be able to explain how it evaluates product quality and what procedures it follows if patients develop an adverse reaction during treatment.

Does NAD+ IV Therapy Work?

NAD+ is important for normal cellular function. However, current evidence is unable to establish that IV NAD+ therapy produces broad wellness or anti-aging benefits. Researchers continue to study NAD+ therapies using high-quality human studies evaluating IV NAD+, but evidence remains limited.

Health experts and scientists are interested in NAD+ because it plays a central role in how cells produce energy and maintain normal biological functions. Also, NAD+ supports enzymes involved in DNA repair, cellular signaling and mitochondrial function. Natural NAD+ levels decline with age, leading researchers to investigate whether restoring NAD+ levels could actually influence age-related health changes or certain medical conditions.

The growing interest in NAD+ IV therapy should not be confused with evidence that it improves health outcomes. A treatment’s biological plausibility does not always translate into measurable clinical benefits. Researchers still need to demonstrate that an increase in NAD+ through IV Therapy produces meaningful improvements in a patient’s health and well-being.

A 2023 systematic review of ten randomized clinical trials evaluating NAD+ raising therapies found that these interventions were generally well tolerated, but the authors concluded that additional high-quality studies are needed to determine their clinical effectiveness. Some reported side effects were headache, fatigue, and sleep disturbance, but they were typically mild. The review found that serious treatment-related adverse events were uncommon in the included studies, but the authors emphasized that larger, higher-quality clinical trials are needed before firm conclusions can be drawn.

A 2021 review published in Nature Reviews Molecular Cell Biology found that increased NAD+ levels influenced biological pathways involved in cellular metabolism and aging. The review still concluded that evidence supporting meaningful clinical benefits for anti-aging and general wellness remains uncertain because of small study sizes, population differences, treatment protocols and limited long-term data.

Health researchers continue to study how NAD+ IV therapies behave in the body. A small 2019 pilot study published in the Frontiers in Aging Neuroscience Journal did find that plasma NAD+ concentrations do not increase during the first 2 hours of a 6-hour infusion. Instead, they found changes related to metabolites, suggesting that infused NAD+ undergoes rapid metabolism instead of simply accumulating in the bloodstream. The IV route bypasses the digestive tract, but it doesn’t establish that IV administration results in better clinical outcomes or greater effectiveness than other NAD+ raising strategies.

Some clinics may advertise NAD+ IV therapy for patients looking for treatment for low energy, healthy aging, mental clarity or even overall wellness. Some patients even report subjective improvements after treatment, but these personal experiences should not be interpreted as proof of effectiveness. Most available studies include relatively small numbers of participants, each using different dosing protocols and often lack placebo comparison groups. This makes it difficult to determine whether reported improvements are attributable to the treatment itself.

The health community needs additional randomized controlled trials with standardized treatment protocols and longer follow-up periods to better understand the safety and effectiveness of IV NAD+ therapy. Until more robust evidence is available, patients should view NAD+ IV therapy only as an area of ongoing research instead of an established treatment for anti-aging or general wellness.

Who May Not Be a Good Candidate for NAD+ IV Therapy?

Eligibility for NAD+ IV therapy depends on an individual’s overall health, medical history, and treatment goals. Healthcare providers will typically determine eligibility through an individualized medical evaluation instead of relying on a universal list of exclusions.

Before prescribing NAD+ IV therapy, a clinician reviews a patient’s current health conditions, medications, previous reactions to IV infusions, and several other factors that could influence treatment safety. The evaluation also helps identify situations in which additional assessment or a different approach is more appropriate.

If a patient is pregnant or breastfeeding, there is limited research evaluating the safety of IV NAD+ therapy during these periods. Also, individuals with kidney disease, liver disease, cardiovascular conditions or disorders that affect fluid balance may also require additional evaluation before receiving IV NAD+ therapy. Finally, patients undergoing treatment for cancer or those with a history of malignancy should discuss whether NAD+ IV therapy is appropriate with the healthcare professional managing their care.

A thorough review of a patient’s medication list is an important part of this screening process. There is not a universal list of medication interactions, but providers should review prescription medications, over-the-counter products, vitamins and even dietary supplements before starting treatment. The review can help identify potential concerns and determine whether additional monitoring is warranted.

An allergic reaction to an IV infusion is also an important discussion point. Many infusion-related symptoms are mild and resolve after slowing or stopping the infusion, but a history of prior reactions can influence how the treatment is administered or whether it should even be recommended.

Because every person’s health history is different, there is no single list of people who should or should not receive NAD+ IV therapy. That’s why an individualized medical assessment remains the safest way to determine whether treatment is appropriate and to weigh the potential benefits against the known risks and the current limitations of the available evidence.

Where Can You Get NAD+ IV Therapy?

Interest in NAD+ IV therapy has grown in recent years. As a result, it is now available through a growing number of clinics across the United States. Several types of healthcare and wellness providers, such as physician-led longevity clinics, medical IV therapy centers and even some mobile IV services, offer NAD+ therapy.

Many providers may offer similar services, but the level of medical oversight, treatment protocols and patient monitoring can differ significantly. Instead of choosing a provider based on convenience or marketing claims, patients should understand who is really involved in their care and how treatment decisions are made.

NAD+ IV therapy is often seen as a part of broader healthy aging or preventive health programs at physician-led longevity and wellness clinics. The practices typically offer doctor consultations, laboratory testing and individualized treatment plans based on a patient’s medical history and goals.

Medical IV therapy clinics are another common setting for NAD+ infusions. Many facilities employ registered nurses or other licensed clinicians to administer treatments under direct physician oversight. Patients will likely complete a consultation before their first appointment, undergo a brief health screening, and then receive monitoring throughout their infusion.

Mobile IV therapy providers have grown more common in some areas. The convenient services bring IV therapy directly to a patient’s home, hotel or even workplace. However, state regulations governing mobile IV services often differ, so patients should confirm who performs a medical evaluation, who administers the infusion and whether a licensed clinician remains available if symptoms develop during treatment.

Finally, regional infusion clinics and wellness centers may also offer NAD+ IV therapy. Some are part of a larger healthcare organization, while others operate independently. As with any provider, medication formulations and treatment protocols likely vary by location.

The following list of providers is an example of organizations that advertise NAD+ IV therapy or related services. Their mention is intended for informational purposes only and should not be interpreted as an endorsement or recommendation. Services offered, clinician involvement, and treatment offerings can change over time.

Restore Hyper Wellness

Restore Hyper Wellness is a multi-location wellness company offering IV therapies at their participating locations. According to the company, patients can expect an initial consultation, eligibility screening, IV placement and continued monitoring by their trained clinical staff. Services vary by location, so patients should confirm which treatments are available and who oversees their care before scheduling an appointment.

Drip Hydration

Drip Hydration is a mobile IV therapy provider in many metropolitan areas. The company offers in-home and even hotel-based appointments and locations where services are available. Before booking, it’s important to verify clinician involvement, eligibility requirements and emergency procedures, as service models and state regulations differ by market.

Next Health

Next Health is a longevity-focused wellness company offering NAD-related therapies at select clinics. The services offered vary by location, and patients should ask whether an in-person medical evaluation is required before treatment and what level of monitoring is provided during the infusion.

The DRIPBaR

The DRIPBaR operates IV wellness clinics in multiple states and offers a variety of IV therapies, including NAD+ at participating locations. Treatment availability and clinical protocols may differ between clinics.

Hydration Room

Hydration Room is an IV therapy provider that only serves select regional markets. Anyone interested in treatment should ensure that NAD+ IV therapy is available at their preferred location while also asking about the clinic’s medical screening process, product sourcing and follow-up care.

How to Choose an NAD+ IV Therapy Provider

Safety is the most important factor when choosing an NAD+ IV therapy provider. It’s important that patients understand who oversees their care, how treatment decisions are made, where the injectable product is sourced, and what safety procedures are in place in case complications occur. That’s why choosing a therapy provider involves much more than comparing prices or appointment availability.

Medical oversight is an important consideration when evaluating an NAD+ IV therapy provider. A licensed and experienced clinician should review medical history, determine whether someone is an appropriate candidate, and answer any questions about potential risks and expected outcomes. Some clinics do require a physician or an advanced practice clinician to evaluate patients before treatment. However, others use telehealth consultations depending on state regulations.

It’s important to know who places and also monitors the IV infusion. Intravenous therapy should be performed by qualified healthcare professionals trained to recognize infusion-related complications so they can respond appropriately if symptoms develop.

Another important consideration is the product being administered. Individuals may wish to ask whether the infusion contains NAD+ or another related compound, such as nicotinamide riboside and what dose is being prescribed. Compounded products are regulated differently than FDA-approved medications, so transparency about product sourcing is a vital part of informed decision-making.

A reputable clinic should also explain how it determines the infusion rate. NAD+ IV therapy is commonly administered slowly since the infusion rate can influence tolerability. It’s important to understand how the infusion will be monitored and what steps staff will take if nausea, abdominal discomfort, chest pressure or other concerning symptoms occur during treatment.

It is also reasonable to ask whether emergency equipment is available and how the clinic responds if an infusion-related reaction occurs. Emergency preparedness is a key consideration since serious complications, although uncommon, can happen with NAD+ infusions. Patients might want to know how symptoms are managed and whether a licensed clinician remains immediately available throughout treatment to provide insight into the clinic’s safety practices.

Finally, patients should understand exactly what is included in their quoted price. Some NAD+ providers will bundle the medical consultation, infusion supplies, follow-up care and monitoring into a single fee. However, others can charge separately for each service. Asking for a clear explanation of cost before starting treatment can help avoid unexpected expenses and compare providers more accurately.

Questions to Ask Before Booking

Question	Why It Matters
Who will review my medical history and determine whether I’m a candidate for NAD+ IV therapy?	Clarifies the level of medical oversight before treatment begins.
Will a licensed clinician be available during my infusion?	Helps patients understand how symptoms or emergencies would be managed if they occur.
Who will place and monitor my IV?	Explains which healthcare professional is responsible for administering and monitoring treatment.
What ingredient and dose will I receive?	Confirms whether the infusion contains NAD+ or another formulation and allows patients to compare treatment protocols.
How is the infusion rate determined?	Infusion rate may affect both treatment duration and tolerability.
Where is the injectable product sourced, and is it compounded?	Compounded products are not FDA-approved. Asking whether a 503A pharmacy or a 503B outsourcing facility prepares the product, and whether preparation follows USP 797, gives a specific answer about sterile-compounding standards.
What happens if I develop symptoms during the infusion?	Helps patients understand how the clinic responds to infusion-related reactions or medical emergencies.
What is included in the quoted price?	Clarifies whether consultation, medication, monitoring, supplies, and follow-up care are included in the overall cost.

NAD+ IV Therapy FAQs

Preparation instructions vary by clinic and an individual’s medical history. However, some providers recommend eating a light meal before an NAD+ IV infusion. Patients should follow the specific guidance provided by their healthcare provider before the appointment.

There is not a universal recommendation, but many people are able to drive after an NAD+ IV infusion. If patients feel any symptoms during treatment, the provider may recommend arranging transportation home to stay safe. Patients should follow their clinic’s discharge instructions.

Many people report subjective improvements that last several days or longer, but there is not a well-established answer to this question. Also, some notice little or no change with therapy. More research is needed to draw conclusions about how long any potential effects of NAD+ IV therapy may last.

Typically, NAD+ IV therapy is not covered by health insurance since it is considered a wellness treatment. Coverage does vary depending on the patient’s insurance plan, reason for treatment, and provider prescribing. Patients should contact both their insurance company and the clinic to determine whether any portion of the treatment may be covered.

Mobile IV therapy providers offer NAD+ infusions in patients’ homes, hotels, or workplaces where permitted by state regulations. Patients should ensure that the service is both available in their area and includes an appropriate medical evaluation by qualified clinical staff.

NAD+ IV therapy delivers nicotinamide adenine dinucleotide through an IV infusion. Nicotinamide riboside (NR) is a precursor that the body converts into NAD+ through normal metabolic pathways. Both are studied for their effects on NAD+ metabolism, but are different compounds and not interchangeable.